Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

30 March 2024 : Clinical Research

Han Fei Wang^12CDEF, Ying Chen^12G, Bang Cao^3E, Jing Pei^12A*

DOI: 10.12659/MSM.943049

Med Sci Monit 2024; 30:e943049

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 3 Baseline characteristics in 128 patients with TNBC.

Variables	All patients (N=127)		HSP90α <81.09 (N=52)		HSP90α ≥81.09 (N=75)		χ2	p Value
Variables	N	%	N	%	N	%	χ2	p Value
Age							0.12	0.73
≤60	49	38.58	21	40.38	28	37.33
>60	78	61.42	31	59.62	47	62.67
Drink							2.66	0.1
No	55	43.31	27	51.92	28	37.33
Yes	72	56.69	25	48.08	47	62.67
BMI							0.22	0.64
<28	76	59.84	30	57.69	46	61.33
≥28	51	40.16	22	42.31	29	38.67
T							2.13	0.14
1, 2	49	38.58	24	46.15	25	33.33
3, 4	78	61.42	28	53.85	50	66.67
N							4.14	<0.05
0	32	25.2	18	34.62	14	18.67
1, 2, 3	95	74.8	34	65.38	61	81.33
M							0.06	0.81
0	70	55.12	28	53.85	42	56.00
1	57	44.88	24	46.15	33	44.00
TNM							13.71	<0.001
I+II	30	23.62	21	40.38	9	80.77
III+IV	97	76.38	31	59.62	66	19.23
Surgery							0.17	0.68
Yes	96	75.59	18	34.62	16	12.00
No	31	24.41	34	65.38	36	48.00
CEA							0.01	0.93
<5	41	32.28	17	32.69	24	32.00
≥5	86	67.72	35	67.31	51	68.00
CA199							0.24	0.63
<40	70	55.12	30	57.69	40	53.33
≥40	57	44.88	22	42.31	35	46.67
CA125							0.61	0.43
<35	93	73.23	40	76.92	53	70.67
≥35	34	26.77	12	23.08	22	29.33

Back to the Article